PANNA

First reported use of elvitegravir and cobicistat during pregnancy

13 Mar, 2016

Authors: Schalkwijk S, Colbers A, Konopnicki D, Greupink R, Russel FG, Burger D; PANNA network. Published in: AIDS. 2016;30(5):807-8. Abstract not available
Read More

Darunavir population pharmacokinetics in pregnancy

30 Dec, 2015

Authors: Moltò J, Valle M, Colbers A, Clotet V, Burger D. Published: 16th edition of the International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 26th – 28th…
Read More

Raltegravir in HIV-1 Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy

01 Sep, 2015

Authors: Blonk MI, Colbers AP, Hidalgo-Tenorio C, et al. Pharmacokinetics of Newly Developed Antiretroviral Agents in HIV-Infected Pregnant Women PANNA Network; PANNA Network. Published in: Clin Infect Dis. 2015; 61(5):809-816.  BackgroundThe use of raltegravir in human…
Read More

Ritonavir pharmacokinetics in pregnancy

30 Aug, 2015

Authors: Colbers A, Clotet V, Burger D. Published: 16th edition of the International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 26th – 28th 2015, Westin Alexandria  
Read More

Etravirine pharmacokinetics during pregnancy and postpartum

30 Aug, 2015

Authors: Best B, Colbers A, Wang J, Taylor G, Stek A, van Kasteren M, Mirochnick M, Burger D. Published: 24th Conference on Retroviruses and Opportunistic Infections, March 23rd-26th 2015, Seattle.…
Read More

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women

22 Jul, 2015

Authors: Colbers A, Best B, Schalkwijk S, et al. PANNA Network and the IMPAACT 1026 Study Team. Published in: Clin Infect Dis. 2015; 61(10):1582-1589. Objective To describe the pharmacokinetics of maraviroc in human…
Read More

Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women

01 Feb, 2015

Authors: Colbers A, Molto J, Ivanovic J, et al. PANNA Network Published in: J Antimicrob Chemother. 2015; 70(2):534-542 Objectives To describe the pharmacokinetics of darunavir in pregnant HIV-infected women in the third trimester and post-partum. Patients and Methods…
Read More

Atazanavir exposure is effective during pregnancy regardless of tenofovir use

01 Jan, 2015

Authors: Colbers A, Hawkins D, HidalgoTenorio C, et al. Published in: Antivir Ther. 2015; 20(1):57-64 Background We studied the effect of pregnancy on atazanavir pharmacokinetics in the presence and absence of tenofovir. Methods This was a non-randomized,…
Read More

Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases

30 Dec, 2014

Authors: Colbers A,  Gingelmaier A, van der Ende M, Rijnders, B, Burger D. Published in: AIDS 2014;28(2): 288-290
Read More

Effective exposure to atazanavir during pregnancy, regardless of tenofovir use

30 Aug, 2014

Authors:  Colbers A, Hawkins D, Hidalgo-Tenorio C, van der Ende M, Kabeya K, Gingelmaier A, Weizsäcker K, Lambert J, Rockstroh J, Burger D; on behalf of the PANNA network Published:…
Read More

A comparison of the pharmacokinetics of raltegravir during pregnancy and postpartum

30 Aug, 2014

Authors: Blonk M, Colbers A, Hidalgo-Tenorio C, Weizsäcker K, Moltó J, Hawkins D, van der Ende M, Gingelmaier A, Taylor G, Burger D; on behalf of the PANNA network Published:…
Read More

Low darunavir exposure during pregnancy with 800/100mg darunavir/r QD dosing

30 Aug, 2014

Authors: Colbers A, Moltó J, Ivanovic J, Hawkins D, Sadiq T, Kabeya K,  Gingelmaier A, Weizsäcker K, Taylor G, Burger D; on behalf of the PANNA network Published: 23rd Conference…
Read More

A comparison of the pharmacokinetics of maraviroc during pregnancy and postpartum

30 Aug, 2013

Authors:  Colbers A, Brookie B, Wang J, Stek A, Hidalgo-Tenorio C, Hawkins D, Taylor G, Capparelli E, Burger D, Mirochnick M; on behalf of the PANNA network Published: 20th Conference…
Read More

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

13 Mar, 2013

Authors: Colbers AP, Hawkins DA, Gingelmaier A, et al. Published in: Aids. 2013; 27(5):739-748. Objective To describe the pharmacokinetics of tenofovir and emtricitabine in the third trimester of pregnant HIV-infected women and at postpartum. Design A nonrandomized, open-label, multicentre phase…
Read More

A comparison of the pharmacokinetics of tenofovir during pregnancy and post-partum

30 Aug, 2012

Authors: Colbers A, Taylor G, Moltó J, Ivanovic J, Wyen C, Schwarze-Zander C, Weizsäcker K, Gingelmaier A, Hawkins D, Sadiq T, Kabamba K, Burger D; on behalf of the PANNA…
Read More

A comparison of the pharmacokinetics of darunavir, atazanavir and ritonavir during pregnancy and post-partum

30 Aug, 2012

Authors: Colbers A, Moltó J, Ivanovic J, Hidalgo-Tenori C, Weizsäcker K, van der Ende I, Hawkins D, Taylor G, Sadiq T,  Burger D; on behalf of the PANNA network Published:…
Read More

A comparison of the pharmacokinetics of raltegravir during pregnancy and post-partum

30 Aug, 2011

Authors: Colbers A, Taylor G, Moltó J, Ivanovic J, Taylor G, Branco T, Wyen C, van der Ende I, Gomes da Silva H, Burger D; on behalf of the PANNA…
Read More
1 2